HealthInvest Partners’s BeOne Medicines Ltd ONC Stock Holding History

HealthInvest Partners’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10M	Sell	35,180 -6,537	-16%	-$1.93M	2.7%	13
2026 Q1	$12.1M	Buy	41,717 +1,285	+3%	+$416K	3.92%	4
2025 Q4	$12.3M	Buy	40,432 +10,099	+33%	+$3.31M	3.92%	7
2025 Q3	$10.3M	Buy	30,333 +5,947	+24%	+$1.81M	4.07%	6
2025 Q2	$5.9M	Sell	24,386 -755	-3%	-$185K	2.53%	15
2025 Q1	$6.84M	Buy	25,141 +14,241	+131%	+$3.33M	3.02%	15
2024 Q4	$2M	Buy	+10,900	New	+$2.23M	0.95%	27

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HealthInvest Partners's ONC Position: Q2 2026 in Review

HealthInvest Partners reduced its BeOne Medicines Ltd (ONC) stake by 16% in Q2 2026, selling an estimated $1.93M and leaving 35,180 shares worth $10M. The position accounts for 2.7% of the portfolio, ranked #13.

HealthInvest Partners first reported a position in ONC in Q4 2024 and has held it in 7 quarters since. The position peaked at $12.3M in Q4 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

HealthInvest Partners held 35,180 shares of BeOne Medicines Ltd worth $10M as of Q2 2026.
HealthInvest Partners sold 6,537 BeOne Medicines Ltd shares in Q2 2026, an estimated $1.93M.
BeOne Medicines Ltd made up 2.7% of HealthInvest Partners's portfolio in Q2 2026, its #13 holding.
HealthInvest Partners first reported a position in BeOne Medicines Ltd in Q4 2024 and has held it in 7 quarters since.
HealthInvest Partners's BeOne Medicines Ltd position peaked at $12.3M in Q4 2025.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.